<DOC>
	<DOCNO>NCT01764178</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics Pitavastatin Valsartan co-administration Livalo fix combination drug healthy male subject .</brief_summary>
	<brief_title>Pharmacokinetic Study LivaloÂ® Fixed Combination Drug Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Healthy male volunteer Age 2055 year time Screening BMI 1926 kg/m2 time Screening Received investigational drug within 90 day prior first dose study drug</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pitavastatin</keyword>
	<keyword>Valsartan</keyword>
</DOC>